Steven Cohen Tyra Biosciences, Inc. Transaction History
Point72 Asset Management, L.P.
- $40.1 Billion
- Q1 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 49,600 shares of TYRA stock, worth $518,319. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,600
Previous 49,600
-0.0%
Holding current value
$518,319
Previous $461,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TYRA
# of Institutions
123Shares Held
55.1MCall Options Held
25KPut Options Held
5.4K-
Ra Capital Management, L.P. Boston, MA10.6MShares$111 Million2.05% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$42.6 Million90.83% of portfolio
-
Nextech Invest Ag4.06MShares$42.4 Million10.51% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$42.4 Million8.77% of portfolio
-
Bvf Inc San Francisco, CA3.94MShares$41.2 Million1.61% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $439M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...